{"id":"https://openalex.org/W2079035972","doi":"https://doi.org/10.1109/tbme.2014.2313226","title":"Chemotherapy Drug Scheduling for the Induction Treatment of Patients With Acute Myeloid Leukemia","display_name":"Chemotherapy Drug Scheduling for the Induction Treatment of Patients With Acute Myeloid Leukemia","publication_year":2014,"publication_date":"2014-03-25","ids":{"openalex":"https://openalex.org/W2079035972","doi":"https://doi.org/10.1109/tbme.2014.2313226","mag":"2079035972","pmid":"https://pubmed.ncbi.nlm.nih.gov/24686224"},"language":"en","primary_location":{"id":"doi:10.1109/tbme.2014.2313226","is_oa":false,"landing_page_url":"https://doi.org/10.1109/tbme.2014.2313226","pdf_url":null,"source":{"id":"https://openalex.org/S5240358","display_name":"IEEE Transactions on Biomedical Engineering","issn_l":"0018-9294","issn":["0018-9294","1558-2531"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310319808","host_organization_name":"Institute of Electrical and Electronics Engineers","host_organization_lineage":["https://openalex.org/P4310319808"],"host_organization_lineage_names":["Institute of Electrical and Electronics Engineers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IEEE Transactions on Biomedical Engineering","raw_type":"journal-article"},"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.tara.tcd.ie/bitstream/2262/104397/1/Pefani%20et%20al%2c%20IEEE%202014.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005860733","display_name":"Eleni Pefani","orcid":null},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"E. Pefani","raw_affiliation_strings":["Centre of Process Systems Engineering, Department of Chemical Engineering, Imperial College London, London, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Process Systems Engineering, Department of Chemical Engineering, Imperial College London, London, U.K","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042492602","display_name":"Nicki Panoskaltsis","orcid":"https://orcid.org/0000-0001-8972-5697"},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"N. Panoskaltsis","raw_affiliation_strings":["Department of Haematology, Imperial College London, London, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Imperial College London, London, U.K","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048473531","display_name":"Athanasios Mantalaris","orcid":"https://orcid.org/0000-0001-6183-0292"},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Mantalaris","raw_affiliation_strings":["Centre of Process Systems Engineering, Department of Chemical Engineering, Imperial College London, London, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Process Systems Engineering, Department of Chemical Engineering, Imperial College London, London, U.K","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062286648","display_name":"Michael C. Georgiadis","orcid":"https://orcid.org/0000-0002-2016-5131"},"institutions":[{"id":"https://openalex.org/I21370196","display_name":"Aristotle University of Thessaloniki","ror":"https://ror.org/02j61yw88","country_code":"GR","type":"education","lineage":["https://openalex.org/I21370196"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"M. C. Georgiadis","raw_affiliation_strings":["Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece","institution_ids":["https://openalex.org/I21370196"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112300827","display_name":"E.N. Pistikopoulos","orcid":null},"institutions":[{"id":"https://openalex.org/I4210108286","display_name":"Process Systems Enterprise (United Kingdom)","ror":"https://ror.org/01s4j6j10","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210108286"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"E. N. Pistikopoulos","raw_affiliation_strings":["Centre of Process Systems Engineering, Department of Chemical Engineering, London, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Process Systems Engineering, Department of Chemical Engineering, London, U.K","institution_ids":["https://openalex.org/I4210108286"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.4448,"has_fulltext":true,"cited_by_count":38,"citation_normalized_percentile":{"value":0.93060168,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"61","issue":"7","first_page":"2049","last_page":"2056"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9995999932289124,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9995999932289124,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9983000159263611,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9973999857902527,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myeloid-leukemia","display_name":"Myeloid leukemia","score":0.713089108467102},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.6452718377113342},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"Chemotherapy","score":0.6327272653579712},{"id":"https://openalex.org/keywords/cytarabine","display_name":"Cytarabine","score":0.6242203712463379},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"Daunorubicin","score":0.5180561542510986},{"id":"https://openalex.org/keywords/oncology","display_name":"Oncology","score":0.4991648197174072},{"id":"https://openalex.org/keywords/leukemia","display_name":"Leukemia","score":0.4598331153392792},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"Induction chemotherapy","score":0.44818970561027527},{"id":"https://openalex.org/keywords/acute-leukemia","display_name":"Acute leukemia","score":0.4356168508529663},{"id":"https://openalex.org/keywords/drug","display_name":"Drug","score":0.41960522532463074},{"id":"https://openalex.org/keywords/cancer-research","display_name":"Cancer research","score":0.3761937916278839},{"id":"https://openalex.org/keywords/pharmacology","display_name":"Pharmacology","score":0.34992724657058716},{"id":"https://openalex.org/keywords/algorithm","display_name":"Algorithm","score":0.3395683765411377},{"id":"https://openalex.org/keywords/internal-medicine","display_name":"Internal medicine","score":0.33534595370292664},{"id":"https://openalex.org/keywords/computer-science","display_name":"Computer science","score":0.20672807097434998}],"concepts":[{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.713089108467102},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6452718377113342},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6327272653579712},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.6242203712463379},{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.5180561542510986},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4991648197174072},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4598331153392792},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.44818970561027527},{"id":"https://openalex.org/C2776863199","wikidata":"https://www.wikidata.org/wiki/Q976388","display_name":"Acute leukemia","level":3,"score":0.4356168508529663},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41960522532463074},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3761937916278839},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34992724657058716},{"id":"https://openalex.org/C11413529","wikidata":"https://www.wikidata.org/wiki/Q8366","display_name":"Algorithm","level":1,"score":0.3395683765411377},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33534595370292664},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.20672807097434998}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1109/tbme.2014.2313226","is_oa":false,"landing_page_url":"https://doi.org/10.1109/tbme.2014.2313226","pdf_url":null,"source":{"id":"https://openalex.org/S5240358","display_name":"IEEE Transactions on Biomedical Engineering","issn_l":"0018-9294","issn":["0018-9294","1558-2531"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310319808","host_organization_name":"Institute of Electrical and Electronics Engineers","host_organization_lineage":["https://openalex.org/P4310319808"],"host_organization_lineage_names":["Institute of Electrical and Electronics Engineers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IEEE Transactions on Biomedical Engineering","raw_type":"journal-article"},{"id":"pmid:24686224","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24686224","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IEEE transactions on bio-medical engineering","raw_type":null},{"id":"pmh:oai:tara.tcd.ie:2262/104397","is_oa":true,"landing_page_url":"http://hdl.handle.net/2262/104397","pdf_url":"https://www.tara.tcd.ie/bitstream/2262/104397/1/Pefani%20et%20al%2c%20IEEE%202014.pdf","source":{"id":"https://openalex.org/S4306400387","display_name":"Trinity's Access to Research Output (TARA) (Trinity College Dublin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I205274468","host_organization_name":"Trinity College Dublin","host_organization_lineage":["https://openalex.org/I205274468"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:tara.tcd.ie:2262/104397","is_oa":true,"landing_page_url":"http://hdl.handle.net/2262/104397","pdf_url":"https://www.tara.tcd.ie/bitstream/2262/104397/1/Pefani%20et%20al%2c%20IEEE%202014.pdf","source":{"id":"https://openalex.org/S4306400387","display_name":"Trinity's Access to Research Output (TARA) (Trinity College Dublin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I205274468","host_organization_name":"Trinity College Dublin","host_organization_lineage":["https://openalex.org/I205274468"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"},"sustainable_development_goals":[{"score":0.800000011920929,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"awards":[{"id":"https://openalex.org/G7481831220","display_name":null,"funder_award_id":"226462","funder_id":"https://openalex.org/F4320334678","funder_display_name":"European Research Council"}],"funders":[{"id":"https://openalex.org/F4320334678","display_name":"European Research Council","ror":"https://ror.org/0472cxd90"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2079035972.pdf","grobid_xml":"https://content.openalex.org/works/W2079035972.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1574190284","https://openalex.org/W1956730086","https://openalex.org/W1963900483","https://openalex.org/W1964505039","https://openalex.org/W1975997904","https://openalex.org/W1998256451","https://openalex.org/W2001838945","https://openalex.org/W2009660703","https://openalex.org/W2033277681","https://openalex.org/W2034203400","https://openalex.org/W2043408890","https://openalex.org/W2043707675","https://openalex.org/W2044210486","https://openalex.org/W2052811447","https://openalex.org/W2090431728","https://openalex.org/W2094726739","https://openalex.org/W2169658509","https://openalex.org/W2403598312"],"related_works":["https://openalex.org/W2147459960","https://openalex.org/W2801436543","https://openalex.org/W1964648983","https://openalex.org/W3046856303","https://openalex.org/W4313390310","https://openalex.org/W2187158199","https://openalex.org/W2077348867","https://openalex.org/W1818146702","https://openalex.org/W2902719404","https://openalex.org/W1506042288"],"abstract_inverted_index":{"Leukemia":[0],"is":[1,75,118,161,191,209,220],"an":[2,242],"immediately":[3],"life-threatening":[4,39],"cancer":[5],"wherein":[6],"immature":[7],"blood":[8,19,24],"cells":[9],"are":[10,48,124,143],"overproduced,":[11],"accumulate":[12],"in":[13,50],"the":[14,164,174,203,210,225,234,237],"bone":[15],"marrow":[16],"(BM)":[17],"and":[18,20,23,35,45,70,83,108,120,153,166,205,222],"causes":[21],"immune":[22],"system":[25],"failure.":[26],"Treatment":[27],"with":[28,65,93],"chemotherapy":[29,63,88],"can":[30,36],"be":[31,38,179,198],"intensive":[32,62,87,152],"or":[33],"nonintensive":[34,79,154],"also":[37],"since":[40],"only":[41],"relatively":[42],"few":[43],"patient-specific":[44],"leukemia-specific":[46],"factors":[47],"considered":[49],"current":[51],"protocols.":[52,155],"We":[53],"have":[54],"already":[55],"presented":[56,144],"a":[57,85,146,206],"mathematical":[58],"model":[59,74],"for":[60,84,145,224,245],"one":[61],"cycle":[64,112,122,135],"intravenous":[66],"(i.v.)":[67],"daunorubicin":[68],"(DNR),":[69],"cytarabine":[71],"(Ara-C).":[72],"This":[73,217],"now":[76],"extended":[77],"to":[78,126,162,181],"subcutaneous":[80],"(SC)":[81],"Ara-C":[82],"standard":[86,149],"course":[89,147],"(four":[90],"cycles),":[91],"consistent":[92],"clinical":[94],"practice.":[95],"Model":[96],"parameters":[97,123],"mainly":[98],"consist":[99],"of":[100,105,110,148,158,202,214,239],"physiological":[101],"patient":[102,227],"data,":[103],"indicators":[104],"tumor":[106,165],"burden":[107],"characteristics":[109],"cell":[111,121,134,195],"kinetics.":[113],"A":[114],"sensitivity":[115],"analysis":[116],"problem":[117,219],"solved":[119,223],"identified":[125],"control":[127],"treatment":[128,150,172,246],"outcome.":[129],"Simulation":[130],"results":[131,231],"using":[132,151],"published":[133],"data":[136],"from":[137,236],"two":[138,226],"acute":[139],"myeloid":[140],"leukemia":[141],"patients":[142],"The":[156,193,230],"aim":[157],"remission-induction":[159],"therapy":[160],"debulk":[163],"achieve":[167],"normal":[168,194],"BM":[169,189],"function;":[170],"by":[171],"completion,":[173],"total":[175],"leukemic":[176],"population":[177,215],"should":[178,197],"reduced":[180],"at":[182,186],"most":[183],"10(9)":[184],"cells,":[185],"which":[187],"point":[188],"hypoplasia":[190],"achieved.":[192],"number":[196],"higher":[199],"than":[200],"that":[201],"leukemic,":[204],"3-log":[207],"reduction":[208],"maximum":[211],"permissible":[212],"level":[213],"reduction.":[216],"optimization":[218,240],"formulated":[221],"case":[228],"studies.":[229],"clearly":[232],"present":[233],"benefits":[235],"use":[238],"as":[241],"advisory":[243],"tool":[244],"design.":[247]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":2}],"updated_date":"2025-11-06T03:46:38.306776","created_date":"2025-10-10T00:00:00"}